(c) 2024 PillSync.com

naproxen tablet delayed release

1 INDICATIONS AND USAGE Naproxen delayed-release tablets are indicated for: The relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • Polyarticular Juvenile Idiopathic Arthritis Naproxen delayed-release tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • polyarticular juvenile idiopathic arthritis

preferred pharmaceuticals inc.


5 years ago OVAL WHITE 93 6 naproxen tablet delayed release

OVAL WHITE 93 6

5 years ago OVAL WHITE 93 6 naproxen tablet delayed release

93 6 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Naproxen Delayed-Release Tablets USP are supplied as follows: 500 mg: white to off-white, capsule-shaped, enteric-coated, unscored tablets imprinted on one side in blue ink with 93-6. They are available in bottles of; Bottles of 20 NDC 68788-6908-2 Bottles of 30 NDC 68788-6908-3 Bottles of 60 NDC 68788-6908-6 Bottles of 90 NDC 68788-6908-9 Bottles of 100 NDC 68788-6908-1 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.


More pills like OVAL 93 6












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site